Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Nov 2021 for PROGENITY, INC., €2,123. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Matthew T. Cooper: trading record in brief
This profile gathers the share dealings of Matthew T. Cooper in Biora Therapeutics, Inc., where the filings describe the role as senior executive. Between 15 May 2021 and 15 November 2021, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 17 November 2021 with a share grant (€2,123) in Biora Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew T. Cooper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
700 shares@ US$3.4737.6% of flowCommon StockSEC:0000899243-21-045044:0
560 shares@ US$1.6614.0% of flowCommon StockSEC:0000899243-21-033251:0
1,400 shares@ US$2.3648.4% of flowCommon StockSEC:0000899243-21-019668:0
3 of 3 declarations
